NICHT-SELEKTIVE KINASEHEMMER

European patent · EP3007689 · In force

Register entry

Publication number
EP3007689
Application number
EP14737648
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 9, 2014
Published
Apr 20, 2016
Granted
Mar 7, 2018
Protection ends at the latest
Jan 8, 2034
Next annual fee due
Jan 31, 2027
IPC classes
C07D 241/20 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
A61K 31/4965 (2006.01)
A61P 9/00 (2006.01)
A61P 11/00 (2006.01)
A61P 29/00 (2006.01)
Priority
US 201361751217 P 10.01.2013
US 201361889887 P 11.10.2013
PCT application
PCT/US2014/010778 09.01.2014
PCT publication
WO2014/110200 17.07.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. May 16, 2020

    Address changed

    Owner
    Pulmokine, Inc., 7 University Place, Room B127, Rensselaer, NY 12144, USA, Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA → Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404, USA, Pulmokine, Inc., 105 Jordan Road, Suite 3, Troy, NY 12180, USA

    Published in Swissreg on 16.05.2020

  6. Mar 7, 2018

    Granted

    Published in Swissreg on 07.03.2018

Parties

Holder

Gilead Sciences, Inc.

333 Lakeside Drive, Foster City, CA 94404, US

Pulmokine, Inc.

105 Jordan Road Suite 3 Troy, NY 12180, US

Inventor

ZISMAN, Lawrence S.

Slingerlands, NY 12159, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.